|
Volumn 24, Issue 3, 2002, Pages 315-323
|
Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD
a a a a a |
Author keywords
Erythropoietin; Hypothalamic pituitary thyroid axis; Peritoneal dialysis; Thyrotropin releasing hormone
|
Indexed keywords
GROWTH HORMONE;
HEMOGLOBIN;
LIOTHYRONINE;
PROLACTIN;
PROTIRELIN;
RECOMBINANT ERYTHROPOIETIN;
THYROTROPIN;
THYROXINE;
BIOLOGICAL MARKER;
CREATININE;
ADULT;
ANEMIA;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HEMODIALYSIS;
HUMAN;
HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM;
LIOTHYRONINE BLOOD LEVEL;
LONG TERM CARE;
MALE;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
PROTIRELIN TEST;
THYROXINE BLOOD LEVEL;
UREMIA;
BLOOD;
CHRONIC KIDNEY FAILURE;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG SCREENING;
HEMATOCRIT;
HYPOPHYSIS ADRENAL SYSTEM;
HYPOTHALAMUS HYPOPHYSIS SYSTEM;
KIDNEY;
METABOLISM;
SECRETION;
THYROID FUNCTION TEST;
TIME;
TREATMENT OUTCOME;
AREA UNDER CURVE;
BIOLOGICAL MARKERS;
COMPARATIVE STUDY;
CREATININE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION;
ERYTHROPOIETIN, RECOMBINANT;
GROWTH HORMONE;
HEMATOCRIT;
HEMOGLOBINS;
HUMAN;
HYPOTHALAMO-HYPOPHYSEAL SYSTEM;
KIDNEY;
KIDNEY FAILURE, CHRONIC;
MALE;
PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;
PITUITARY-ADRENAL SYSTEM;
PROLACTIN;
PROTIRELIN;
THYROID FUNCTION TESTS;
THYROTROPIN;
THYROXINE;
TIME;
TIME FACTORS;
TREATMENT OUTCOME;
HUMANS;
THYROTROPIN-RELEASING HORMONE;
|
EID: 0036022109
PISSN: 0886022X
EISSN: None
Source Type: Journal
DOI: 10.1081/JDI-120005365 Document Type: Article |
Times cited : (7)
|
References (15)
|